Effect of treatment of chronic theileriosis with buparvaquone on milk yields

Summary Chronic, undulatingTheileria annulata infection was diagnosed as the cause of severely depressed milk yields in a herd of 44 Friesian cows in Egypt. The herd was divided at random into two groups of 22; one group was injected intramuscularly with a single dose of the experimental antitheilerial drug, buparvaquone, while the other remained untreated. Over the subsequent seven weeks milk yield in the treated group increased to double that of the untreated group (P<0.05). Pyrexia was controlled within two days of injection of buparvaquone and piroplasm parasitaemia was eliminated in one week. It is suggested that treatment of dairy cattle chronically infected withT. annulata using buparvaquone may have the dual beneficial effect of reducing the pathogenic effects of theileriosis, thereby permitting restoration of an impaired immune system, thus increasing resistance to other infections. If a similar effect could be produced inBos indicus cattle inT. annulata endemic areas, treatment of indigenous cattle with buparvaquone could be a useful alternative to the introduction ofBos taurus blood as a way of boosting milk production.

---

Efecto Sobre La Produccion De Leche Del Tratamiento De La Theileriosis Cronica Con Buparvaquone

Resumen Se diagnosticó infección crónica ondulate deTheileria annulata, en un hato de 44 vacas Friesian en Egipto; la causa fue, la caida severa de la producción láctea. Se dividió el hato al azár, en dos grupos de 22 vacas cada uno; un grupo se inyectó via intramuscular, con una dosis única de la droga experimental buparvaquone y el otro no se trató. Durante las siete semanas subsiguientes, la producción láctea aumentó el doble en el grupo tratado, en relación con el grupo sin tratar (P<0.05). La pirexia fue controlada, dentro de los dos primeros dias después de la inyección de buparvaquone, y la parasitemia por piroplasmas se eliminó en una semana. Se sugiere, que el tratamiento con buparvaquone del genado de leche infectado crónicamente conT. annulata, podría tener doble efecto benéfico, al reducir el efecto patógeno de la theileriosis, permitiendo la restauración del sistema inmunológico, incrementando así la resistencia a otras infecciones. Si un efecto similar se produjera en ganadoBos indicus, en áreas endémicas deT. annulata, el tratamiento del ganado nativo con buparvaquone, podría convertirse en una alternativa a la introducción de sangreBos taurus, para incrementar la producción láctea.

---

Effet Du Traitement De La Theileriose Chronique Par La Buparvaquone Sur Les Rendements Laitiers

Résumé L'infection chronique et à rechutes àTheileria annulata a été diagnostiquée comme étant la cause de rendements laitiers fortement déprimés dans un troupeau de 44 vaches frisonnes en Egypte. Le troupeau fut partagé, au hasard, en deux groupes de 22; un groupe a reçu par voie intramusculaire, une dose unique d'un médicament antitheileriose expériemental, la buparvaquone, tandis que l'autre n'était pas traité. Pendant les sept semaines suivantes, le rendement laitier du groupe traité a doublé par rapport à celui du groupe non triaté (P<0.05). L'hyperthermie a été contrôlée dans les deux jours suivant l'injection de buparvaquone, et la parantémie à piroplasme éliminée en une semaine. Il est suggéré que le traitement du bétail laitier chroniquement infecté parT. annulata à l'aide de la buparvaquone peut avoir le double effet bénéfique de réduire les effects pathologiques de la theilériose, permettant ainsi la restauration d'un système immunitaire affaibli, ce qui augmente la résistance aux autres infections. Si un effet similaire pouvait être produit chez le bétailBos indicus des régions à endémicitéT annulata, le traitement du bétail indigène avec la buparvaquone pourrait être une alternative utile à l'introduction du sangBos taurus dans le but de stimuler la production laitière.

     

Effects of supplementation with green tea by‐products on growth performance,meat quality,blood metabolites and immune cell proliferation in goats

Forty‐eight castrated male goats were used to determine the effects of feeding green tea by‐products (GTB) on growth performance, meat quality, blood metabolites and immune cell proliferation. Experimental treatments consisted of basal diets supplemented with four levels of GTB (0%, 0.5%, 1.0% or 2.0%). Four replicate pens were assigned to each treatment with three goats per replicate. Increasing dietary GTB tended to linearly increase the overall average weight gain and feed intake (p = 0.09). Water holding capacity, pH and sensory attributes of meat were not affected by GTB supplementation, while cooking loss was reduced both linearly and quadratically (p < 0.01). The redness (linear; p = 0.02, quadratic; p < 0.01) and yellowness (quadratic; p < 0.01) values of goat meat were improved by GTB supplementation. Increasing dietary GTB quadratically increased protein and decreased crude fat (p < 0.05), while linearly decreased cholesterol (p = 0.03) content of goat meat. The proportions of monounsaturated fatty acid, polyunsaturated fatty acid (PUFA) and n‐6 PUFA increased linearly (p < 0.01) and n‐3 PUFA increased quadratically (p < 0.05) as GTB increased in diets. Increasing dietary GTB linearly increased the PUFA/SFA (saturated fatty acid) and tended to linearly and quadratically increase (p ≤ 0.10) the n‐6/n‐3 ratio. The thiobarbituric acid‐reactive substances values of meat were lower in the 2.0% GTB‐supplemented group in all storage periods (p < 0.05). Dietary GTB linearly decreased plasma glucose and cholesterol (p < 0.01) and quadratically decreased urea nitrogen concentrations (p = 0.001). The growth of spleen cells incubated in concanavalin A and lipopolysaccharides medium increased significantly (p < 0.05) in response to GTB supplementation. Our results suggest that GTB may positively affect the growth performance, meat quality, blood metabolites and immune cell proliferation when supplemented as a feed additive in goat diet.     

Downregulation of male-specific cytochrome P450 by profenofos

The health hazards of individual organophosphorus insecticides have been characterized by their acute toxicity, mainly by investigating their cholinesterase inhibition. However, the chronic effects of most of these toxicants on the drug-metabolizing enzymes have not been investigated. Profenofos (O-4-bromo-2-chlorophenyl O-ethyl S-propyl phosphorothioate) is an organophosphorus pesticide widely used in cotton cultivation. In the present study, we investigated the effect of profenofos on male-specific cytochrome P450 (CYP) enzymes in adult Wistar rats. We orally administered 17.8 mg/kg body weight, twice weekly for 65 days. Profenofos downregulated levels of hepatic and testicular CYP2C11 and CYP3A2 mRNA and protein expression. Testicular aromatase (CYP19A) mRNA was decreased in the profenofos-treated rats compared to controls. Overall, the present study suggests that profenofos acts as an endocrine disruptor of male-specific CYP enzymes and affects testosterone concentration, which implicates its deleterious effects on animal or human males chronically exposed to organophosphorus pesticide.     

Identification of Arcanobacterium (Trueperella) abortisuis, a novel species of veterinary importance, by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)

In the present study A. (T.) abortisuis isolated from pigs and bovines could be reliably identified by determination of phenotypic properties, genotypically by polymerase chain reaction with the help of A. (T.) abortisuis 16s-23S rDNA intergenic spacer region specific oligonucleotide primer and by Matrix-Assisted Laser Desorption Ionization-Time Of Flight mass spectrometry (MALDI-TOF MS). The latter appeared to be a promising tool for fast and cost effective identification of this species and might help to elucidate the role A. (T.) abortisuis plays in infections of pigs, bovines, possibly other animals or humans.     

Incidence,risk factors,and outcomes for early postoperative seizures in dogs with rostrotentorial brain tumors after intracranial surgery

BackgroundSeizures in the early postoperative period after intracranial surgery may affect outcome in dogs.ObjectivesTo determine the incidence of early postoperative seizures (EPS) in dogs with brain tumors, identify specific risk factors for EPS, and determine if EPS affects outcome.AnimalsEighty‐eight dogs that underwent 125 intracranial surgeries for diagnosis and treatment of rostrotentorial brain tumors.MethodsRetrospective cohort study. All patients with a diagnosis of rostrotentorial brain tumor from 2006 to 2020 were included. Early postoperative seizures were diagnosed by observation of seizure activity within 14 days of neurosurgery. Previously diagnosed structural epilepsy, perioperative anticonvulsant drug (ACD) use, magnetic resonance imaging (MRI), and tumor characteristics were evaluated. Outcome measures included neurologic and nonneurologic complications, duration of hospitalization, and survival to discharge.ResultsDogs with rostrotentorial brain tumors had EPS after 16/125 (12.8%) neurosurgical procedures (95% confidence interval [CI], 7%‐19%). Presence of previous structural epilepsy was not associated with EPS risk (P = 1). Perioperative ACD use also was not associated with EPS (P = .06). Dogs with EPS had longer hospitalization (P < .001), were more likely to have neurologic complications postsurgery (P = .01), and were less likely to survive to discharge (P = .01).Conclusions and Clinical ImportanceIt is difficult to predict which dogs are at risk of EPS because the presence of previous structural epilepsy and the use of perioperative ACDs was not associated with EPS. However, seizures in the early postoperative period are clinically important because affected dogs had prolonged hospitalization, more neurologic complications, and decreased short‐term survival.